Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | RARB | P10826 | 8/20 | 0.48 |
| ▸ | RARA | P10276 | 2/20 | 0.48 |
| ▸ | RARG | P13631 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | MTOR | P42345 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | BCHE | P06276 | 1/20 | 0.45 |
| ▸ | GPR3 | P46089 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20814553 | 1.00 | HSD11B1 (0.49) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL20814575 | 1.00 | HSD11B1 (0.49) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL20814645 | 1.00 | HSD11B1 (0.49) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL20814576 | 1.00 | HSD11B1 (0.49) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL3153624 | 0.97 | HSD11B1 (0.51) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL3162990 | 0.97 | HSD11B1 (0.51) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL3159165 | 0.95 | HSD11B1 (0.53) | HSD11B1RARBRARARARGMEN1 | |
| SCHEMBL2463519 | 0.92 | HSD17B10 (0.47) | RARBRARARARGMEN1ALDH1A1 | |
| SCHEMBL3168671 | 0.91 | PSMB5 (0.55) | HSD11B1RARBPSMB5TRPV1BCHE | |
| Hydrogen Sulfide SCHEMBL20335338 | 0.89 | SIGMAR1 (0.51) | HSD11B1RARBRARARARGTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352308-B2 | Compound and semiconductor material containing same | DIC CORPORATION (JP) | 2022-06-07 | — | — | US | disclosed |
| US-20190077732-A1 | NOVEL COMPOUND AND SEMICONDUCTOR MATERIAL CONTAINING SAME | DIC CORPORATION (JP) | 2019-03-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077732-A1 | NOVEL COMPOUND AND SEMICONDUCTOR MATERIAL CONTAINING SAME | SCO2, CNOT1, CNOT9 | HSD11B1 703/4885RARB 1158/4885RARA 920/4885 |
| US-11352308-B2 | Compound and semiconductor material containing same | SCO2, CNOT1, CNOT9 | HSD11B1 626/4885RARB 1055/4885RARA 732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.